The Chief Executive Officer (CEO) Per Walday has today, 28th January 2015, subscribed for 10.872 new shares in PCI Biotech Holding ASA (the "Company") at a subscription price of NOK 10 per share by exercising 10.872 subscription rights in the Company's ongoing rights issue. After the transaction Per Walday has a total shareholding in the company of 22.872 shares, 0 subscription rights in the rights issue and 186.000 options to acquire shares in the Company.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.